Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas

British Journal of Cancer

Volumn 75, Issue 2, 1997, Pages 208-212

  Filipits, M ^a   Suchomel, R W ^a   Dekan, G ^a   Stiglbauer, W ^b   Haider, K ^b   Depisch, D ^b   Pirker, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b General Hospital Wiener Neustadt   (Austria)

Author keywords

Colorectal carcinoma; MRP gene; Multidrug resistance; Multidrug resistance associated protein

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GLYCOPROTEIN P; MESSENGER RNA; MITOMYCIN C; MITOXANTRONE; MONOCLONAL ANTIBODY; PROTEIN;

ADULT; AGED; ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031014543     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.35     Document Type: Article

References (36)

1. Barrand MA, Heppell-Parton AC, Wright KA, Rabbitts PH and Twentyman PR (1994) A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 86: 110-117
2. Beck WT (1989) Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 81: 1683-1685
3. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the n-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036-5040
4. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG and Cole SPC (1995) Sequential coexpression of the multidrug resistance genes MRP and mdrI and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 55: 459-462
5. Chin K-V, Ueda K, Pastan I and Gottesman MM (1992) Modulation of activity of the promoter of the human MDRI gene by Ras and p53. Science 255: 459-462
6. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU. Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
7. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910
8. De Angelis P, Stokke T, Smedshammer L, Lothe RA, Lehne G, Chen Y and Clausen OPF (1995) P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo. Br J Cancer 72: 307-311
9. Filipits M, Suchomel RW, Zöchbauer S, Malayeri R and Pirker R (1996a) Clinical relevance of drug resistance genes in malignant diseases. Leukemia 10 (suppl. 3): 10-17
10. Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D and Pirker R (1996b) MRP and MDRI gene expression in primary breast carcinomas. Clin Cancer Res 2: 1231-1237
11. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124
12. Gottesman MM and Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163-12166
13. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361
14. 1 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 54: 5788-5792
15. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
16. Kruh GD, Chan A, Myers K, Gaughan K, Miki T and Aaronson SA (1994) Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 54: 1649-1652
17. Lehnert M (1993) Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues. Eur J Cancer 29A: 636-638
18. 4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 271: 9675-9682
19. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K and Ludwig H (1993) The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 71: 2454-2460
20. Milroy R on behalf of the West of Scotland Lung Cancer Research Group and the Aberdeen Oncology Group (1993) A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. Br J Cancer 68: 813-818
21. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB (1990) Quantitative analysis of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164
22. Nooter K, Westerman AM, Flens MJ, Zaman GJR, Scheper RJ, Van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratama JW, Kok T, Eggermont AMM, Bosman FT and Stoter G (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310
23. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SI, and Haber M (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334: 231-238
24. Pastan I and Gottesman M (1987) Mutliple-drug resistance in human cancer. N Engl J Med 316: 1388-1393
25. Pirker R, Keilhauer G, Raschack M, Lechner C and Ludwig H (1990) Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil. Int J Cancer 45: 916-919
26. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, Ludwig H and Lechner K (1991) MDRI gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708-712
27. Pirker R, Wallner J, Gsur A, Götzl M, Zöchbauer S, Scheitbauer W and Depisch D (1993) MDRI gene expression in primary colorectal carcinomas. Br J Cancer 68: 691-694
28. Roepe PD (1995) The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim Biophys Acta 1241: 385-406
29. Roepe PD, Wei LY, Cruz J and Carlson D (1993) Lower electrical membrane potential and altered pH homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochimistry 32: 11042-11056
30. Simon SM and Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91: 3497-3504
31. Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee JJ and Safa AR (1994) Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion. DNA ploidy, and disease relapse. Cancer 74: 2908-2917
32. Thomas GA, Barrand MA, Stewart S, Rabbitts PH, Williams ED and Twentyman PR (1994) Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. Eur J Cancer 30A: 1705-1709
33. Twentyman PR (1992) MDRI (P-glycoprotein) gene expression-implications for resistance modifier trials. J Natl Cancer Inst 84: 1458-1460
34. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB and Coon JS (1991) Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726
35. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, De Haas M, Smith AJ, Broxterman HJ, Mulder NH, De Vries EGE, Baas F and Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750
36. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mulder HS, Lankelma J.